Impilo
Regeringsgatan 48, Stockholm, Stockholm County, 103 65, Sweden
Overview
Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Its starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which they operate in order to remain successful in the long term. It was founded in 2017 and is based in 2017 and is based in Stockholm, Sweden.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 6
Sector focus
- Financial Services
- Health Care
- Venture Capital
Investment portfolio
- ArgusEye
Participated · Equity · Apr 2026
ArgusEye develops the Auga™ platform to provide real-time monitoring for bioprocesses in biopharma manufacturing. The company aims to enable more data-driven and continuous manufacturing workflows by delivering live process insights. With the newly announced €3.3M funding round, ArgusEye intends to accelerate technology development and expand commercially into key markets. Management said the capital will help scale the platform and broaden the customer base globally. The announcement did not disclose revenue, users, or a valuation.